This is Part 2 of a three-part series on India's healthcare system. Part 1 examined why India does not have enough doctors, and why it cannot produce them fast enough.

The question patients actually ask

If you want to understand Indian healthcare, do not start with hospitals. Start with how patients make decisions.

When someone falls ill; really ill, not a seasonal cold but something that frightens them, they rarely begin by comparing institutions. They do not look up accreditation scores or audit infection rates. They ask a simpler question: who is the best doctor?

In India, healthcare trust is not institutional. It is personal.

This is worth pausing on, because it runs counter to how healthcare is supposed to work in theory. We tend to think of hospitals as the unit of medical quality; the building, the machines, the protocols, the brand. But in India, the unit of trust is the individual doctor. Patients follow them across hospitals. They wait for them, travel for them, and pay premium rates simply for access to them. The hospital is often secondary, almost incidental.

Why personal trust fills the vacuum

Part of it is structural. Healthcare is deeply uncertain. Patients cannot independently assess whether a treatment plan is optimal. They cannot read an MRI, evaluate a surgical technique, or audit a prescription. Reputation becomes a substitute for information they cannot gather themselves. And in India, where public discourse about medical quality is thin and independent accreditation data is not widely understood, personal reputation fills the vacuum.

Part of it is cultural. The doctor in Indian society occupies a position closer to the elder or the sage than to the service provider. Deference runs deep. Questioning is limited. Second opinions, in many families, carry the weight of disloyalty; as if seeking another view were an insult to the first doctor rather than a reasonable precaution.

The result is that a physician's authority is rarely challenged even when it perhaps should be.

The economics of concentrated trust

This concentration of trust creates economic power.

A star doctor becomes a demand generator. A busy cardiologist at a large hospital does not just treat patients; he attracts them, and through them, revenue. The hospital's occupancy, the utilisation of its diagnostics floor, the footfall in its pharmacy; all of it flows partly from the drawing power of key doctors. This makes the hospital structurally dependent on these individuals in ways that no hospital administrator openly admits but every one of them privately understands.

The balance of power shifts. It is not the hospital that controls the patient relationship; it is often the doctor.

Layered onto this are informal incentive structures that the system has long tolerated. Referral payments (one doctor directing patients to another in exchange for a fee) are illegal but persistent. Pharmaceutical companies have historically funded overseas conferences, offered prescription-linked benefits, and cultivated relationships through gift-giving. A survey published in the Indian Journal of Medical Ethics found that a large majority of doctors received some form of industry promotion, ranging from branded stationery to sponsored travel.¹ The Medical Council of India's guidelines on the matter have existed for years, but enforcement has been inconsistent.

Time pressure and the incentive to intervene

Time pressure compounds the problem. When a doctor is seeing 80 to 100 patients a day, a realistic number in a busy urban practice, the time available for each patient shrinks to minutes. Deep clinical reasoning gives way to heuristics and pattern matching. Investigations get ordered defensively, partly to cover diagnostic uncertainty, partly because a referral to diagnostics is both quick and financially structured to incentivise it.

The system rewards intervention more than observation. A 2018 study in the BMJ found that caesarean sections in Indian private facilities ran at nearly double the WHO recommended rate, a figure that suggests the incentive to intervene often outweighs the case for watchful waiting.²

None of this is unique to India. Fee-for-service medicine everywhere creates pressure toward more procedures. What makes India distinctive is the combination: the personal nature of trust, the thinness of institutional alternatives, and the sheer volume pressure on individual doctors. These three things together produce a system where the doctor's judgment, already under financial pressure, is exercised at extraordinary speed, with patients who are culturally disinclined to question it.

World-class at the top, fragile underneath

The model works, for those who can afford it. A wealthy patient in Mumbai or Delhi with access to a well-regarded specialist can receive care that would not be out of place in London or Singapore. India's private hospital sector, valued at nearly $99 billion in 2023 and growing at roughly 8% annually, is demonstrably capable of excellence.³ Apollo, Fortis, Manipal: these are institutions that attract medical tourists from across the world precisely because their quality is genuine.

But the model does not scale. And it creates fragility.

A system built around individual doctors rather than institutional capability is only as strong as those individuals. When the star surgeon retires, when the well-known cardiologist moves hospitals, patient flows follow. The institution that invested in infrastructure and equipment is left holding assets that were partly justified by a person, not a system. And the patient who cannot afford the star, or who lives three hours from the city where the star practises, is simply outside the model.

This is not a criticism of individual doctors. Most are working with integrity under enormous pressure. It is an observation about how a system that should distribute trust through institutions has instead concentrated it through personalities, and what that concentration costs everyone below the top.

The deeper problem is economic. Capital in Indian healthcare flows toward where trust and revenue are already concentrated; which means it flows away from the majority. That pattern, and what it would take to change it, is what the final piece in this series examines.

References
1. Srinivasan S, Doctors and the Pharmaceutical Industry, Indian Journal of Medical Ethics, Vol. X No. 1, 2013.
2. Boatin AA et al., Within country inequalities in caesarean section rates: observational study of 72 low and middle income countries, BMJ, 2018.
3. IBEF, Indian Healthcare Industry, citing India Brand Equity Foundation data, 2024.

This is Part 2 of a three-part series on India's healthcare system.  |  Part 1: A Sick system treating a sicker population.  |  Part 3: Healthcare Investments in India is not missing. Its misplaced!